Mascaux C, Iannino N, Martin B, Paesmans M, Berghmans T, Dusart M, Haller A, Lothaire P, Meert AP, Noel S, et al.: The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2005,92(1):131–139. 10.1038/sj.bjc.6602258
Article
CAS
PubMed Central
PubMed
Google Scholar
Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP: Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 2001,18(4):705–719. 10.1183/09031936.01.00062201
Article
CAS
PubMed
Google Scholar
Zheng Z, Chen T, Li X, Haura E, Sharma A, Bepler G: DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med 2007,356(8):800–808. 10.1056/NEJMoa065411
Article
CAS
PubMed
Google Scholar
Stevens C, La Thangue NB: The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 2004,3(8–9):1071–1079.
Article
CAS
Google Scholar
Ingram L, Munro S, Coutts AS, La Thangue NB: E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit. Cell Death Differ 2011,18(1):122–132. 10.1038/cdd.2010.70
Article
CAS
PubMed Central
PubMed
Google Scholar
Van Den Broeck A, Nissou D, Brambilla E, Eymin B, Gazzeri S: Activation of a Tip60/E2F1/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin. Carcinogenesis 2012,33(2):320–325. 10.1093/carcin/bgr292
Article
CAS
PubMed
Google Scholar
Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, et al.: Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000,407(6804):645–648. 10.1038/35036614
Article
CAS
PubMed
Google Scholar
Stiewe T, Putzer BM: Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 2000,26(4):464–469. 10.1038/82617
Article
CAS
PubMed
Google Scholar
Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ: Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996,85(4):537–548. 10.1016/S0092-8674(00)81254-4
Article
CAS
PubMed
Google Scholar
Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Livingston DM, Orkin SH, Greenberg ME: E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996,85(4):549–561. 10.1016/S0092-8674(00)81255-6
Article
CAS
PubMed
Google Scholar
Moller MB, Kania PW, Ino Y, Gerdes AM, Nielsen O, Louis DN, Skjodt K, Pedersen NT: Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Leukemia 2000,14(5):898–904. 10.1038/sj.leu.2401761
Article
CAS
PubMed
Google Scholar
Rabbani F, Richon VM, Orlow I, Lu ML, Drobnjak M, Dudas M, Charytonowicz E, Dalbagni G, Cordon-Cardo C: Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 1999,91(10):874–881. 10.1093/jnci/91.10.874
Article
CAS
PubMed
Google Scholar
Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL: Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Clin Cancer Res 2003,9(10 Pt 1):3705–3711.
CAS
PubMed
Google Scholar
Lee J, Park CK, Park JO, Lim T, Park YS, Lim HY, Lee I, Sohn TS, Noh JH, Heo JS, et al.: Impact of E2F-1 expression on clinical outcome of gastric adenocarcinoma patients with adjuvant chemoradiation therapy. Clin Cancer Res 2008,14(1):82–88. 10.1158/1078-0432.CCR-07-0612
Article
CAS
PubMed
Google Scholar
Evangelou K, Kotsinas A, Mariolis-Sapsakos T, Giannopoulos A, Tsantoulis PK, Constantinides C, Troupis TG, Salmas M, Kyroudis A, Kittas C, et al.: E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J Clin Pathol 2008,61(5):601–605. 10.1136/jcp.2007.050963
Article
CAS
PubMed
Google Scholar
Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK: Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. J Pathol 2002,198(2):157–162. 10.1002/path.1185
Article
CAS
PubMed
Google Scholar
Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ: E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 2000,9(4):395–401.
CAS
PubMed
Google Scholar
Volm M, Koomagi R, Rittgen W: Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma. Int J Cancer 1998,79(3):294–299. 10.1002/(SICI)1097-0215(19980619)79:3<294::AID-IJC15>3.0.CO;2-8
Article
CAS
PubMed
Google Scholar
Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H: E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res 2007,13(23):6938–6946. 10.1158/1078-0432.CCR-07-1539
Article
CAS
PubMed
Google Scholar
Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C, Papavassiliou AG: Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002,198(2):142–156. 10.1002/path.1121
Article
CAS
PubMed
Google Scholar
Yamazaki K, Hasegawa M, Ohoka I, Hanami K, Asoh A, Nagao T, Sugano I, Ishida Y: Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. J Clin Pathol 2005,58(9):904–910. 10.1136/jcp.2004.023127
Article
CAS
PubMed Central
PubMed
Google Scholar
Kwon MJ, Nam ES, Cho SJ, Park HR, Shin HS, Park JH, Park CH, Lee WJ: E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma. Ann Surg Oncol 2010,17(2):564–571. 10.1245/s10434-009-0767-z
Article
PubMed
Google Scholar
Cho EC, Zheng S, Munro S, Liu G, Carr SM, Moehlenbrink J, Lu YC, Stimson L, Khan O, Konietzny R, et al.: Arginine methylation controls growth regulation by E2F-1. EMBO J 2012,31(7):1785–1797. 10.1038/emboj.2012.17
Article
CAS
PubMed Central
PubMed
Google Scholar
Hallett RM, Hassell JA: E2F1 and KIAA0191 expression predicts breast cancer patient survival. BMC Res Notes 2011, 4: 95. 10.1186/1756-0500-4-95
Article
CAS
PubMed Central
PubMed
Google Scholar
Hsueh CT, Wu YC, Schwartz GK: UCN-01 suppresses E2F-1 mediated by ubiquitin-proteasome-dependent degradation. Clin Cancer Res 2001,7(3):669–674.
CAS
PubMed
Google Scholar
Novotny GW, Sonne SB, Nielsen JE, Jonstrup SP, Hansen MA, Skakkebaek NE, Rajpert-De Meyts E, Kjems J, Leffers H: Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17–92 cluster. Cell Death Differ 2007,14(4):879–882. 10.1038/sj.cdd.4402090
Article
CAS
PubMed
Google Scholar
Yang G, Zhang R, Chen X, Mu Y, Ai J, Shi C, Liu Y, Sun L, Rainov NG, Li H, et al.: MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 2011,89(10):1037–1050. 10.1007/s00109-011-0775-x
Article
CAS
Google Scholar
Wang HW, Hsueh CT, Lin CF, Chou TY, Hsu WH, Wang LS, Wu YC: Clinical implications of microsomal prostaglandin e synthase-1 overexpression in human non-small-cell lung cancer. Ann Surg Oncol 2006,13(9):1224–1234. 10.1245/s10434-006-9001-4
Article
PubMed
Google Scholar